Brought to you by:
AVF 2022: Six-month CLOUT data indicate ClotTriever can effectively remove full spectrum of thrombus
Six-month outcomes from the ongoing CLOUT registry demonstrate the “safety and efficacy” of the ClotTriever thrombectomy system in a real-world deep vein thrombosis (DVT) population regardless of clot chronicity level, the 2022 annual meeting of the American Venous Forum (AVF)…
AVF 2022: VenoValve improvement ‘maintained’ for 2.5 years without adverse events
Envveno Medical announced positive 30-month data from the first-in-human trial of the VenoValve bioprosthetic potential venous valve replacement during the 2022 American Venous Forum (AVF) annual meeting (VENOUS2022) held in Orlando, Florida (Feb. 23–26). The results showed that VenoValve recipients—now an…
VAM 2022: More science, discussion, streaming
With abstract selection finished this month and the lineup of many other sessions in place, organizers are excited about the offerings of the 2022 Vascular Annual Meeting (VAM). VAM 2022 will be held June 15–18 at the Hynes Convention Center…
Sex discordance and postoperative outcomes: We should be vigilant of a real disparity in health outcomes
The recent JAMA Surgery publication “Association of surgeon-patient sex concordance with postoperative outcomes” is a population-based, retrospective cohort study of more than 1 million patients that concluded “sex discordance between surgeons and patients negatively affected outcomes following common procedures.”1 Furthermore,…
Study ‘supports’ SVS open AAA volume recommendations
A multicenter, retrospective database analysis suggests improved open abdominal aortic aneurysm (AAA) outcomes when surgeon volume is greater than seven cases yearly and performed in hospitals with a 30-day mortality rate less than 5%. “Open AAA repair has decreased in frequency…
Perioperative care in open aortic surgery: SVS and ERAS Society issue consensus statement
The Society for Vascular Surgery (SVS) and the Stockholm, Sweden-based Enhanced Recovery after Surgery (ERAS) Society have released a consensus statement intended to help address perioperative challenges faced by vascular surgery patients. The ERAS pathways have proven beneficial for a…
‘Cheers to 75 Years’: Anniversary Gala tickets go on sale on Feb. 22
How will you help the Society for Vascular Surgery (SVS) celebrate “Cheers to 75 Years?” Maybe it’s offering an adventure in the wilderness, on a mountain or secluded location. Perhaps it’s providing the chance to stay in a house by…
Ra Medical Systems receives FDA approval for increased enrollment in atherectomy clinical trial
Ra Medical Systems, a medical device company focused on developing the excimer laser system to treat vascular diseases, has announced that enrollment has reached 95 subjects in the pivotal clinical trial to evaluate the safety and effectiveness of the DABRA…
SVS PAC: A voice for vascular surgeons on Capitol Hill
As everyone turned the page on 2021 and entered 2022 with a new hope for a return to normalcy, vascular surgeons continue to be at the forefront of the fight to combat the COVID-19 pandemic. Our days and nights are…
VRIC input in 2021 helped strengthen research, says award-winner
The Society for Vascular Surgery (SVS) Vascular Research Initiatives Conference (VRIC) in 2021 helped Sriganesh (Sri) Sharma, MD, better understand his own work. During the free-wheeling discussion following his presentation, “I got a lot of meaningful input into my research,”…